Total adiponectin, but not inflammatory markers C-reactive protein, tumor necrosis factor-α, interluekin-6 and monocyte chemoattractant protein-1, correlates with increasing glucose intolerance in pregnant Chinese-Americans

Journal of Diabetes

Volumn 6, Issue 4, 2014, Pages 360-368

  Kim, So Young ^a   Sy, Vanessa ^a   Araki, Takako ^a   Babushkin, Nicole ^a   Huang, Diana ^a   Tan, Doris ^a   Liao, Emilia ^a   Liu, George ^a   Wan, Stephen ^a   Poretsky, Leonid ^a   Seto Young, Donna ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Chinese pregnant women; Gestational diabetes; Glucose intolerance; HMW adiponectin; Inflammatory markers; T adiponectin

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; ASIAN AMERICAN; BODY MASS; CHINESE; FEMALE; GLUCOSE INTOLERANCE; HUMAN; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROVOCATION TEST; SERUM; YOUNG ADULT; ADOLESCENT; ANALYSIS; BLOOD; DIABETES, GESTATIONAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GLUCOSE BLOOD LEVEL; METABOLISM; PREGNANCY; PROGNOSIS;

ADIPONECTIN; ADOLESCENT; ADULT; ASIAN AMERICANS; BIOMARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHEMOKINE CCL2; DIABETES, GESTATIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-6; PREGNANCY; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84901853330     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12114     Document Type: Article

References (36)

1. Green J, Pawson I, Schumacher L. Glucose tolerance in pregnancy: Ethnic variation and influence of body habits. Am J Obstet Gynecol. 1990; 163: 86-92.
2. Chu SY, Abe K, Hall LR etal. Gestational diabetes mellitus: All Asians are not alike. Prev Med. 2009; 49: 265-268.
3. Mazaki-Tovi S, Romero R, Valsbuch E etal. Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med. 2009; 37: 637-650.
4. Low CF, Tohi ERM, Chong PP etal. Adiponectin SNP45TG is associated with gestational diabetes mellitus. Arch Gynecol Obstet. 2011; 283: 1255-1260.
5. Retnakaran R, Hanley A, Connelly PW etal. Low serum levels of high molecular weight adiponectin in Indo-Asian women during pregnancy. Diabetes Care. 2006; 29: 1377-1379.
6. Choi SH, Kwak SH, Young BS etal. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab. 2008; 93: 3142-3148.
7. Retnakaran R, Hanley A, Raif NW etal. C-reactive protein and gestational diabetes: The central role of maternal obesity. J Clin Endocrinol Metab. 2003; 88: 3507-3512.
8. Wolf M, Sandler L, Hsu K etal. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care. 2003; 26: 819-824.
9. Van der Toll T, Keogh CV, Gurao X etal. Interluekin-6 gen-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis. 1997; 176: 439-444.
10. Morisset AS, Dube MC, Cote JA etal. Circulating interleukin-6 concentrations during and after gestational diabetes mellitus. Acta Obstet Gynecol Scand. 2011; 90: 524-530.
11. Olszewski M, Groot AJ, Dastych J etal. TNF trafficking to human mast cell granules: Mature chain-dependent endocytosis. J Immunol. 2007; 178: 5701-5709.
12. Altinova AE, Toruner F, Bozkurt N. Circulating concentrations of adiponectin and tumor necrosis factor-alpha in gestational diabetes mellitus. Gynecol Endocrinol. 2007; 23: 161-165.
13. Tang X, Asano M, O'Reilly A etal. p53 is an important regulator of CCL2 gene expression. Curr Mol Med. 2012; 12: 929-943.
14. Klein K, Satler M, Elhenicky M etal. Circulating levels of MCP-1 are increased in women with gestational diabetes. Prenat Diagn. 2008; 28: 845-851.
15. Carpenter MW, Coustan DR. Criteria for screening test for gestational diabetes. Am J Obstet Gynecol. 1982; 144: 768-773.
16. Pajvani UB, Du X, Combs TP etal. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: Implications for metabolic regulation and bioactivity. J Biol Chem. 2003; 278: 9073-9085.
17. Hirata A, Kishida K, Kobayashi H etal. Correlation between serum C1q-adiponectin/total adiponectin ratio and polyvascular lesions detected by vascular ultrasonography in Japanese type 2 diabetics. Metabolism. 2013; 62: 376-385.
18. Liu X, Zhang J, Li Y etal. On the relationship between serum total adiponectin and insulin resistance in polycystic ovary syndrome. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010; 27: 636-640 (in Chinese).
19. Bo S, Signorile A, Menato G etal. C-Reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia. J Endocrinol Invest. 2005; 28: 779-786.
20. Carpenter MW. Gestational diabetes, pregnancy hypertension and late vascular disease. Diabetes Care. 2007; 30 (Suppl. 2): S246-250.
21. Friedman J, Kirwan JP, Jilng M etal. Increased skeletal muscle tumor necrosis factor-α and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum. Diabetes. 2008; 57: 606-613.
22. Lappas M, Permezel M, Rice GE. Release of pro-inflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab. 2004; 89: 5627-5633.
23. Kinalski MT, Telejko B, Kuzmicki M etal. Tumor necrosis factor-alpha system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res. 2005; 37: 450-454.
24. Kuzmicki M, Telejko B, Szamatowicz J etal. High resistin and interleukin-6 are associated with gestational diabetes mellitus. Gynecol Endocrinol. 2009; 25: 258-263.
25. Telejko B, Kuzmicki M, Zonenberg A etal. Circulating monocyte chemoattractant protein-1 in women with gestational diabetes. Folia Histochem Cytobiol. 2007; 45 (Suppl. 1): S153-156.
26. Ballestero M, Simon I, Vendrell J etal. Maternal and cord blood adiponectin multimeric forms in gestational diabetes mellitus. Diabetes Care. 2011; 34: 2418-2423.
27. Ota E, Haruna M, Suzuki M. Gestational weight gain and its association with perinatal outcomes in Viet Nam. Bull World Health Organ. 2011; 89: 127-136.
28. Holowko N, Mishra G, Koupil I. Social inequality in excessive gestational weight gain. Int J Obes (Lond). 2014; 38: 91-96.
29. Saucedo R, Zarate A, Basurto L etal. Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Arch Med Res. 2011; 42: 318-323.
30. Gax XL, Yang HX, Zhao Y. Variations of tumor necrosis factor-α, leptin and adiponectin in mid-trimester of gestational diabetes mellitus. Chin Med J. 2008; 121: 701-705.
31. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev. 2011; 10: 319-329.
32. Wikipedia. National register of historic places in Manhattan, Chinatown, Manhattan. Available from: http://en.wikipedia.org (accessed 8 January 2011).
33. Hitchman SC, Fong GT. Gender empowerment and female-to-male smoking prevalence ratios. Bull World Health Organ. 2011; 89: 195-202.
34. Fleming DR. Accuracy of blood glucose monitoring for patients: What it is and how to achieve it. Diabetes Educ. 1994; 20: 495-500.
35. Fogh-Anderson N. Evaluation of HemoCue glucose meter (201 plus): Converting B-glucose to P-glucose. Point of Care: The Journal of Near-Patient Testing & Technology. 2004; 3: 172-175.
36. Warner JV, Wu JY, Buckingham N, McLeod DSA, Mottram B, Carter AC. Can one point of care glucose meter be used for all pediatric and adult hospital patients? Evaluation of three meters, including recently modified test strips. Diabetes Technol Ther. 2011; 13: 55-62.